UC Davis researchers develop Hepatitis virus-like particles to target breast cancer

[News]

UC Davis researchers have developed a way to use the empty shell of a Hepatitis E virus to carry vaccines or drugs into the body. The technique has been tested in rodents as a way to target breast cancer, and is available for commercial licensing through UC Davis Office of Research.

More... (http://www.news-medical.net/news/20160204/UC-Davis-researchers-develop-Hepatitis-virus-like-particles-to-target-breast-cancer.aspx)